This study explored the prognostic significance of HAO1 expression at various molecular levels—gene CN, mRNA, and protein—and its relationship with clinical outcomes in invasive breast cancer, especially in ER+ subtypes. This evidence concerns the gene HAO1 and invasive breast carcinoma.